Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
9.93
+0.09 (0.91%)
At close: Feb 17, 2026, 4:00 PM EST
9.93
0.00 (0.00%)
After-hours: Feb 17, 2026, 4:53 PM EST
Immatics Market Cap
Immatics has a market cap or net worth of $1.33 billion as of February 17, 2026. Its market cap has increased by 106.55% in one year.
Market Cap
1.33B
Enterprise Value
819.50M
1-Year Change
106.55%
Ranking
Category
Stock Price
$9.93
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.33B, an increase of 671.74%. That is a compound annual growth rate of 32.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 1.32B | -6.29% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zenas BioPharma | 1.42B |
| Novavax | 1.41B |
| Savara | 1.38B |
| Intellia Therapeutics | 1.37B |
| Kodiak Sciences | 1.37B |
| Trevi Therapeutics | 1.33B |
| Rapport Therapeutics | 1.33B |
| AtaiBeckley | 1.30B |